tiprankstipranks
Protagonist Therapeutics Inc (PTGX)
:PTGX
US Market

Protagonist Therapeutics (PTGX) Cash flow

Compare
632 Followers

Protagonist Therapeutics Cash Flow

PTGX's free cash flow for Q3 2024 was $-28.64M. For the 2024 fiscal year, PTGX's free cash flow was decreased by $253.64M and operating cash flow was $-27.86M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ 184.15M$ -70.24M$ -108.14M$ -107.86M$ -72.48M
Investing Cash Flow
$ -299.48M$ -39.26M$ 91.47M$ -15.86M$ -90.97M
Financing Cash Flow
$ 25.85M$ 170.48M$ 18.84M$ 129.92M$ 247.63M
End Cash Position
$ 97.47M$ 186.95M$ 125.97M$ 123.89M$ 117.82M
Free Cash Flow
$ 182.80M$ -70.84M$ -108.93M$ -108.97M$ -72.95M
Currency in USD

Protagonist Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis